These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33924142)

  • 21. Aberrant expression of microRNAs in bladder cancer.
    Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
    Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
    Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
    PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
    Wang R; Xu J; Liu H; Zhao Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction.
    Zhong Z; Wu H; Zhong W; Zhang Q; Yu Z
    J Clin Lab Anal; 2020 Mar; 34(3):e23099. PubMed ID: 31721304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating miRNA panels for specific and early detection in bladder cancer.
    Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T
    Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
    Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
    Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
    Kaba M; Pirinççi N; Demir M; Kaba S; Oztuzcu S; Verep S
    Int Urol Nephrol; 2023 Oct; 55(10):2483-2491. PubMed ID: 37338656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulation of seven CpG island-harboring miRNAs in bladder cancer: miR-155 and miR-23b as the most promising oncomiRs.
    Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N
    Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):25-30. PubMed ID: 27064870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
    Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bladder cancer diagnosis with a four-miRNA panel in serum.
    Li X; Chen W; Li R; Chen X; Huang G; Lu C; Wen Z; Peng X; Liu K; Zhang C; Li H; Hu Y; Zhao Z; Tao L; Lai Y
    Future Oncol; 2022 Sep; 18(29):3311-3322. PubMed ID: 36047424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.